Chen, Yangkai – Trademark Portfolio
Entity Type: 01
Chen, Yangkai owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ZOGOO, BARDRIP, IHOUMEX, POTESSA, and RUNSOAR. Of these, 7 are registered. The portfolio spans 7 Nice Classification classes, led by Class 25 (Clothing) and Class 9 (Computers & Electronics). Headquartered in Guangdong.
Jindi Road, Futian District, Shenzhen
Blk B, Bld309, Shawei Industrial Zone
Guangdong 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Chen, Yangkai's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Precious metals and their alloys; jewellery, precious stones; horological instruments
Frequently Asked Questions
How many trademarks does Chen, Yangkai have?
Chen, Yangkai has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does Chen, Yangkai file in?
Chen, Yangkai files trademarks across 7 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 9 (Computers & Electronics), Class 3 (Cosmetics & Cleaning), Class 11 (Environmental Control), Class 8 (Hand Tools). Class 25 covers clothing, footwear, headgear.
What are Chen, Yangkai's most well-known trademarks?
Chen, Yangkai's registered trademark portfolio includes well-known marks such as ZOGOO, BARDRIP, IHOUMEX, POTESSA, and RUNSOAR. These are among 7 currently registered trademarks in the portfolio.
What is Chen, Yangkai's trademark registration success rate?
Chen, Yangkai has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.